October 12, 2020
Cadwalader Intellectual Property Group Chair and Partner Dorothy Auth shares her insights on the timing of Allele Biotech’s patent infringement lawsuits against Pfizer and Regeneron in connection with their use of Allele’s patented molecules to develop COVID-19 treatments. Dorothy also comments on the case’s specific issue of how research tools are used in developing pharmaceutical products.
our latest insights on the impact of COVID-19 to help you navigate this unprecedented environment.
Learn more about the event and watch the on-demand replay here.
Selections to the Lawdragon 500 are limited to no more than 500 lawyers in the country.
Making a Mark on Our Communities: Pro Bono Report 2020